Drug

Pasireotide

76 flagged reaction(s) · 2,408 total co-reports · max PRR 64.2

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Hyperglycaemia	247	64.2	72.1	signal
2	Adrenal Insufficiency	50	39.3	40.2	signal
3	Diabetes Mellitus	244	30.0	33.5	signal
4	Nocturia	37	28.7	29.2	signal
5	Glycosylated Haemoglobin Increased	71	26.5	27.4	signal
6	Faeces Discoloured	46	19.9	20.3	signal
7	Sleep Apnoea Syndrome	40	19.7	20.0	signal
8	Cholelithiasis	65	18.6	19.2	signal
9	Diabetes Mellitus Inadequate Control	35	18.6	18.9	signal
10	Hypoglycaemia	81	15.7	16.2	signal
11	Blood Pressure Systolic Increased	31	14.9	15.1	signal
12	Hepatic Steatosis	29	14.6	14.8	signal
13	Blood Glucose Fluctuation	17	14.5	14.6	signal
14	Nerve Injury	17	14.3	14.4	signal
15	Neoplasm	17	13.9	14.0	signal
16	Blood Glucose Increased	259	12.9	14.4	signal
17	Blood Iron Decreased	16	12.7	12.8	signal
18	Body Temperature Decreased	13	12.3	12.4	signal
19	Blood Glucose Decreased	63	12.3	12.6	signal
20	Brain Neoplasm	11	11.2	11.3	signal
21	Blood Potassium Increased	19	11.0	11.1	signal
22	Type 2 Diabetes Mellitus	39	10.8	11.0	signal
23	Pulmonary Mass	17	10.7	10.8	signal
24	Neoplasm Progression	38	10.2	10.3	signal
25	Blood Urea Increased	17	9.5	9.5	signal
26	Hypercholesterolaemia	9	8.8	8.9	signal
27	Haematocrit Decreased	17	8.0	8.0	signal
28	Lymphocyte Count Decreased	15	8.0	8.0	signal
29	Vitamin D Deficiency	8	7.7	7.7	signal
30	Blood Glucose Abnormal	15	7.6	7.6	signal
31	Inappropriate Schedule Of Drug Administration	58	7.5	7.7	signal
32	Heart Rate Irregular	18	7.4	7.5	signal
33	Cholecystitis	9	7.1	7.1	signal
34	Thirst	13	6.8	6.9	signal
35	Hypophagia	18	6.7	6.7	signal
36	Blood Pressure Fluctuation	16	6.2	6.3	signal
37	Hepatocellular Injury	9	5.9	6.0	signal
38	Limb Discomfort	19	5.8	5.8	signal
39	Eyelid Ptosis	6	5.5	5.5	signal
40	Blood Pressure Increased	90	5.5	5.7	signal
41	Urinary Incontinence	17	5.4	5.4	signal
42	Red Blood Cell Count Decreased	16	5.2	5.3	signal
43	Osteoporosis	23	5.2	5.3	signal
44	Blood Pressure Decreased	36	5.1	5.2	signal
45	Diabetic Ketoacidosis	13	5.1	5.1	signal
46	Cardiomyopathy	8	5.1	5.1	signal
47	Heart Rate Decreased	19	5.1	5.1	signal
48	Needle Issue	15	4.9	4.9	signal
49	Frequent Bowel Movements	14	4.9	4.9	signal
50	Blindness	21	4.8	4.9	signal
51	Head Injury	16	4.8	4.8	signal
52	Disease Progression	59	4.7	4.8	signal
53	Syringe Issue	8	4.3	4.3	signal
54	Cold Sweat	8	4.3	4.3	signal
55	Gallbladder Disorder	8	4.2	4.2	signal
56	Abdominal Pain Lower	11	4.1	4.1	signal
57	Drug Resistance	11	4.0	4.0	signal
58	Electrocardiogram Qt Prolonged	15	3.9	3.9	signal
59	Knee Operation	4	3.9	3.9	signal
60	Inappropriate Schedule Of Product Administration	72	3.8	3.9	signal
61	Ovarian Cyst	4	3.7	3.7	signal
62	Neoplasm Malignant	26	3.7	3.7	signal
63	Thyroid Disorder	6	3.7	3.7	signal
64	Acute Hepatic Failure	5	3.5	3.5	signal
65	Cholecystectomy	4	3.3	3.3	signal
66	Metrorrhagia	6	3.3	3.3	signal
67	Thyroid Cancer	4	3.1	3.1	no signal
68	Malignant Neoplasm Progression	29	2.7	2.7	signal
69	Incorrect Drug Administration Duration	6	2.0	2.0	no signal
70	Injection Site Pruritus	12	1.7	1.7	no signal
71	Product Administered At Inappropriate Site	3	1.5	1.6	no signal
72	Abortion Spontaneous	6	1.4	1.4	no signal
73	Incorrect Route Of Drug Administration	5	1.3	1.3	no signal
74	Injection Site Pain	41	1.3	1.3	no signal
75	Injection Site Erythema	15	1.1	1.1	no signal
76	Gynaecomastia	3	0.9	0.9	no signal